Biota, Daiichi Sankyo sales and marketing update

Daiichi Sankyo will launch Inavir laninamivir 20 mg dry powder inhaler in Japan on Oct. 19 to treat influenza. The second-generation long-acting neuraminidase inhibitor (LANI) was approved in Japan ...